Trial intelligence / Profile preview

STB vs ISB for Shoulder Surgery

NCT03272139Phase 4Completed

Sponsor
Hospital for Special Surgery
Start
Sep 2017
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Hospital for Special Surgery. Primary endpoints: Hemidiaphragmatic Paralysis and Numerical Pain Rating System. Started Sep 2017; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03272139.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03272139.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call